Yet Another Injectable Combo Achieves Near 15% Weight Loss in Trial
(MedPage Today) -- SAN DIEGO -- Another investigational treatment containing a GLP-1 receptor agonist induced major weight loss in people with obesity in a phase II study, though a fourth of participants on the study drug discontinued for toxicity...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Eating Disorders & Weight Management | Heart | Obesity | Study | Toxicology | Weight Loss